The voice of medical imaging and clinical oncology

Darren Morgan

Contact restrictions following radioiodine (I-131) therapy

Radioiodine therapy has been used successfully for more than 60 years. The treatment of thyroid diseases is one of the most frequent medical uses of radioactivity that results in radiation exposure to family and others. Protocols for treatment with I-131 differ slightly from country to country and from hospital to hospital, with varied radioactivities being […]

Dr Aida Hallam, Darren Morgan

Oxford University Hospitals NHS Foundation Trust

Read Article

Advances in selective internal radiotherapy for primary and secondary liver cancer

Liver metastases are the leading cause of death from colorectal cancer (CRC) with a median survival of 19 months when treated with chemotherapy. The increasing incidence of hepatocellular carcinoma and the poor outcomes for intrahepatic cholangiocarcinoma (ICC) also add to the clinical need to develop effective liver-directed treatment strategies. Surgical approaches have led to prolonged […]

Professor Ricky Sharma, Dr Helen Winter, Dr Phil Boardman, Mr Darren Morgan, Dr Tessa Greenhalgh

Oxford University Hospitals NHS Trust

Read Article

Advertise: mechel@radmagazine.com

Subscribe: katherine@radmagazine.com

Call: (01371) 812960

Stay up to date with
RAD Magazine

Sign up for our newsletter.

We care about your data. Read our privacy policy.